N@N

Chi Fong Maintained (CCCC) at Hold with Decreased Target to $2 on, Oct 9th, 2023

Chi Fong of B of A Securities, Maintained "C4 Therapeutics, Inc." (CCCC) at Hold with Decreased Target from $5 to $2 on, Oct 9th, 2023.

Chi has made no other calls on CCCC in the last 4 months.

There is 1 other peer that has a rating on CCCC. Out of the 1 peers that are also analyzing CCCC, 0 agree with Chi's Rating of Hold.

This is the rating of the analyst that currently disagrees with Chi

---

• Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $17 on, Wednesday, August 9th, 2023